申请人:Bionomics Limited
公开号:EP2524912A1
公开(公告)日:2012-11-21
The present invention relates to Kv1.3 potassium channel blockers of Formula (I) and their use in the treatment of autoimmune and inflammatory diseases.
本发明涉及公式(I)的Kv1.3钾通道阻滞剂及其在治疗自身免疫和炎症性疾病中的应用。